A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors

Reiss, KA; Yuan, Y; Ueno, NT; Johnson, ML; Gill, S; Dees, EC; Chao, J; Angelos, M; Shestova, O; Serody, JS; Priceman, S; Barton, D; Swaby, RF; Ronczka, A; Condamine, T; Cushing, D; Qureshi, R; Kemp, M; Klichinsky, M; Abdou, Y

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):